What is RARE’s calculated intrinsic value vs its market price?
Ultragenyx Pharmaceutical Inc. (RARE) current market price is $26.53. Tickerplace Pro unlocks the dollar intrinsic value estimate. This is a model output, not a recommendation.
Search companies or stocks...
Ultragenyx Pharmaceutical Inc. (RARE) valuation snapshot is loading. Our models compare market price to fair value using DCF, P/E, and P/S frameworks.
Confidence score is based on the magnitude of the gap vs the modeled estimate.
Fair value estimate
Unlock fair valueCurrent price
$26.53
For Ultragenyx Pharmaceutical Inc., intrinsic value ties fair value to sustainable cash generation and compares that level with the live market price.
Historical valuation for RARE shows cycles where multiples expanded and compressed; today’s positioning is one data point in that range.
The gap comes down to growth, risk, and return on capital in the models. Cross-check with live ratios and financials linked from this page.
Ultragenyx Pharmaceutical Inc. (RARE) current market price is $26.53. Tickerplace Pro unlocks the dollar intrinsic value estimate. This is a model output, not a recommendation.
Intrinsic value is an estimate of what RARE shares may be worth based on fundamentals rather than today's price alone. See the valuation snapshot on this page for the latest model output. Tickerplace Pro unlocks the full dollar fair value estimate.
Tickerplace calculates RARE's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to show the calculated gap.
The fair value gap is the percentage difference between RARE’s market price and the modeled fair value estimate. Use it as one research input alongside fundamentals — not as a recommendation.
Peers for RARE: open their calculated fair value vs price view.